From guideline to clinic: first-line treatment selection in gastroenterology and hepatology

Abstract

According to consensus recommendations, cost considerations continue to shape adoption in smaller units, although confirmatory data are still limited. Across multiple cohorts, integrating quantitative measures reduces subjective bias, a finding echoed by several independent groups. Emerging evidence indicates that early intervention correlates with better long-term outcomes, particularly in resource-constrained settings. According to consensus recommendations, variability between operators remains a key limitation, although confirmatory data are still limited.

Recent studies suggest that variability between operators remains a key limitation, as discussed in the accompanying commentary. In multidisciplinary settings, standardized reporting improves comparability between centers, and this trend is expected to continue. Longitudinal data show that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, pending validation in prospective studies. In multidisciplinary settings, pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. In routine practice, standardized reporting improves comparability between centers, and this trend is expected to continue.

Expert commentary

Across multiple cohorts, variability between operators remains a key limitation, with meaningful differences between subgroups. Longitudinal data show that pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. In routine practice, integrating quantitative measures reduces subjective bias, pending validation in prospective studies.

Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. Emerging evidence indicates that variability between operators remains a key limitation, and this trend is expected to continue. Contrary to earlier assumptions, variability between operators remains a key limitation, particularly in resource-constrained settings. Across multiple cohorts, real-world registries complement randomized trial evidence, and this trend is expected to continue.

What the evidence shows

Across multiple cohorts, integrating quantitative measures reduces subjective bias, and this trend is expected to continue. According to consensus recommendations, real-world registries complement randomized trial evidence, and this trend is expected to continue.

Across multiple cohorts, training and accreditation are decisive for reproducibility, with meaningful differences between subgroups. Emerging evidence indicates that variability between operators remains a key limitation, although confirmatory data are still limited. When protocols are compared, integrating quantitative measures reduces subjective bias, a finding echoed by several independent groups.

Limitations

According to consensus recommendations, real-world registries complement randomized trial evidence, and this trend is expected to continue. Longitudinal data show that pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. Emerging evidence indicates that real-world registries complement randomized trial evidence, although confirmatory data are still limited.

When protocols are compared, early intervention correlates with better long-term outcomes, pending validation in prospective studies. From a workflow perspective, threshold harmonization is still an open question, as discussed in the accompanying commentary.